www.natlawreview.com
Open in
urlscan Pro
54.173.98.74
Public Scan
Submitted URL: http://article.natlawreview.com/ls/click?upn=GTiwZsWzj-2BF7xplzeOlMa16Ijwl5D1VCA2XHUnSOqOdpgoIoHL8AKYm-2FbJxkCc-2F-2Fl9IcHjkQ1vJ...
Effective URL: https://www.natlawreview.com/article/new-guidelines-good-manufacturing-practices-concerning-medical-devices-mexico?utm_source...
Submission: On February 07 via api from US — Scanned from DE
Effective URL: https://www.natlawreview.com/article/new-guidelines-good-manufacturing-practices-concerning-medical-devices-mexico?utm_source...
Submission: On February 07 via api from US — Scanned from DE
Form analysis
2 forms found in the DOM<form class="gsc-search-box gsc-search-box-tools" accept-charset="utf-8">
<table cellspacing="0" cellpadding="0" class="gsc-search-box">
<tbody>
<tr>
<td class="gsc-input">
<div class="gsc-input-box" id="gsc-iw-id1">
<table cellspacing="0" cellpadding="0" id="gs_id50" class="gstl_50 gsc-input" style="width: 100%; padding: 0px;">
<tbody>
<tr>
<td id="gs_tti50" class="gsib_a"><input autocomplete="off" type="text" size="10" class="gsc-input" name="search" title="search" id="gsc-i-id1" dir="ltr" spellcheck="false"
style="width: 100%; padding: 0px; border: none; margin: 0px; height: auto; outline: none;"></td>
<td class="gsib_b">
<div class="gsst_b" id="gs_st50" dir="ltr"><a class="gsst_a" href="javascript:void(0)" title="Clear search box" role="button" style="display: none;"><span class="gscb_a" id="gs_cb50" aria-hidden="true">×</span></a></div>
</td>
</tr>
</tbody>
</table>
</div>
</td>
<td class="gsc-search-button"><button class="gsc-search-button gsc-search-button-v2"><svg width="13" height="13" viewBox="0 0 13 13">
<title>search</title>
<path
d="m4.8495 7.8226c0.82666 0 1.5262-0.29146 2.0985-0.87438 0.57232-0.58292 0.86378-1.2877 0.87438-2.1144 0.010599-0.82666-0.28086-1.5262-0.87438-2.0985-0.59352-0.57232-1.293-0.86378-2.0985-0.87438-0.8055-0.010599-1.5103 0.28086-2.1144 0.87438-0.60414 0.59352-0.8956 1.293-0.87438 2.0985 0.021197 0.8055 0.31266 1.5103 0.87438 2.1144 0.56172 0.60414 1.2665 0.8956 2.1144 0.87438zm4.4695 0.2115 3.681 3.6819-1.259 1.284-3.6817-3.7 0.0019784-0.69479-0.090043-0.098846c-0.87973 0.76087-1.92 1.1413-3.1207 1.1413-1.3553 0-2.5025-0.46363-3.4417-1.3909s-1.4088-2.0686-1.4088-3.4239c0-1.3553 0.4696-2.4966 1.4088-3.4239 0.9392-0.92727 2.0864-1.3969 3.4417-1.4088 1.3553-0.011889 2.4906 0.45771 3.406 1.4088 0.9154 0.95107 1.379 2.0924 1.3909 3.4239 0 1.2126-0.38043 2.2588-1.1413 3.1385l0.098834 0.090049z">
</path>
</svg></button></td>
<td class="gsc-clear-button">
<div class="gsc-clear-button" title="clear results"> </div>
</td>
</tr>
</tbody>
</table>
</form>
<form class="gsc-search-box gsc-search-box-tools" accept-charset="utf-8">
<table cellspacing="0" cellpadding="0" class="gsc-search-box">
<tbody>
<tr>
<td class="gsc-input">
<div class="gsc-input-box" id="gsc-iw-id2">
<table cellspacing="0" cellpadding="0" id="gs_id51" class="gstl_51 gsc-input" style="width: 100%; padding: 0px;">
<tbody>
<tr>
<td id="gs_tti51" class="gsib_a"><input autocomplete="off" type="text" size="10" class="gsc-input" name="search" title="search" id="gsc-i-id2" dir="ltr" spellcheck="false"
style="width: 100%; padding: 0px; border: none; margin: 0px; height: auto; outline: none;"></td>
<td class="gsib_b">
<div class="gsst_b" id="gs_st51" dir="ltr"><a class="gsst_a" href="javascript:void(0)" title="Clear search box" role="button" style="display: none;"><span class="gscb_a" id="gs_cb51" aria-hidden="true">×</span></a></div>
</td>
</tr>
</tbody>
</table>
</div>
</td>
<td class="gsc-search-button"><button class="gsc-search-button gsc-search-button-v2"><svg width="13" height="13" viewBox="0 0 13 13">
<title>search</title>
<path
d="m4.8495 7.8226c0.82666 0 1.5262-0.29146 2.0985-0.87438 0.57232-0.58292 0.86378-1.2877 0.87438-2.1144 0.010599-0.82666-0.28086-1.5262-0.87438-2.0985-0.59352-0.57232-1.293-0.86378-2.0985-0.87438-0.8055-0.010599-1.5103 0.28086-2.1144 0.87438-0.60414 0.59352-0.8956 1.293-0.87438 2.0985 0.021197 0.8055 0.31266 1.5103 0.87438 2.1144 0.56172 0.60414 1.2665 0.8956 2.1144 0.87438zm4.4695 0.2115 3.681 3.6819-1.259 1.284-3.6817-3.7 0.0019784-0.69479-0.090043-0.098846c-0.87973 0.76087-1.92 1.1413-3.1207 1.1413-1.3553 0-2.5025-0.46363-3.4417-1.3909s-1.4088-2.0686-1.4088-3.4239c0-1.3553 0.4696-2.4966 1.4088-3.4239 0.9392-0.92727 2.0864-1.3969 3.4417-1.4088 1.3553-0.011889 2.4906 0.45771 3.406 1.4088 0.9154 0.95107 1.379 2.0924 1.3909 3.4239 0 1.2126-0.38043 2.2588-1.1413 3.1385l0.098834 0.090049z">
</path>
</svg></button></td>
<td class="gsc-clear-button">
<div class="gsc-clear-button" title="clear results"> </div>
</td>
</tr>
</tbody>
</table>
</form>
Text Content
Skip to main content FEBRUARY 7, 2022 VOLUME XII, NUMBER 38 * Login * FB * twt * link * home * rss Advertisement × search * logo * Publish / Advertise with Us * Publish * Advertise * Publishing Firms * E Newsbulletins * Law Student Writing Contest * Contact Us * Terms of Use * Privacy Policy * Join Our Team * Search * Trending Legal News * Most Recent * Legal News Podcast * What's Trending * Type of Law * Antitrust Law * Bankruptcy & Restructuring * Biotech, Food & Drug * Business of Law * Construction & Real Estate * Cybersecurity Media & FCC * Election & Legislative * Environmental & Energy * Family, Estates & Trusts * Financial, Securities & Banking * Global * Health Care Law * Immigration * Insurance * Intellectual Property Law * Labor & Employment * Litigation * Public Services, Infrastructure, Transportation * Tax * White Collar Crime & Consumer Rights * E Newsbulletins * Legal Educational Events * NLR Blog * Search * About Us * About the NLR * NLR Team * Publishing Firms * E Newsbulletins * NLR Thought Leadership Awards * 2018 * 2019 * 2020 * 2021 * NLR Blog * Contact Us * Terms of Use * Privacy Policy * Search * Contact Us * Contact Us * E Newsbulletins * Publish * Advertise * Law Student Writing Contest * Search * Quick Links * Legal News Podcast * Type of Law * Antitrust Law * Bankruptcy & Restructuring * Biotech, Food & Drug * Business of Law * Construction & Real Estate * Cybersecurity Media & FCC * Election & Legislative * Environmental & Energy * Family, Estates & Trusts * Financial, Securities & Banking * Global * Health Care Law * Immigration * Insurance * Intellectual Property Law * Labor & Employment * Litigation * Public Services, Infrastructure, Transportation * Tax * White Collar Crime & Consumer Rights * E Newsbulletins * Legal Educational Events * Law Student Writing Contest * NLR Blog * Contact Us * Search * ENEWSBULLETINS × search 6 New Articles Advertisement FEBRUARY 07, 2022 * Cadwalader Cabinet February 7, 2021: Risky Business by: Cadwalader, Wickersham & Taft LLP and Steven Lofchie * First Circuit Creates Split Regarding Federal Court Jurisdiction Over... by: Patrick M. Curran, Jr. and Jesse R. Dill * Prop 65 Settlement on Lead in Infant Formula by: Food and Drug Law at Keller and Heckman * Treasury Targets Nonfungible Tokens by: Scott H. Kimpel * Proposed Money Market Fund Reforms Related to Negative Interest Rates... by: Jon-Luc Dupuy and Clair E. Pagnano * “Administrative History?” – President Releases Guidebook for... by: John W. Hutchinson * A Five Step Approach to Raising Your Profile and Being More... by: Stefanie M. Marrone * Between the Legal Lines: Women in the Law in 2022- Part 1 [PODCAST] by: Andrea Bricca * New UK International Data Transfer Agreement and a New Approach to UK... by: Susan L. Foster, Ph.D. * California Has Its Own Flavor of WARN Requirements That Employers... by: Sayaka Karitani * Spring Brings New Laws for New York Employers by: Jerrold F. Goldberg and Nicholas A. Corsano * 4 Crucial Points About the Employment Discrimination Case Against the... by: Eric Bachman * There’s More! Tri-Agencies Provide Clarifying Guidance on Group... by: Russell L Hirschhorn * Use of Opioid Medications By Applicant For Forklift Job Was Not... by: Kathryn J. Russo * CMS Provides Relief to Hospitals Through Acute Hospital Care at Home... by: Eli Tilley and Charles A. Sinsel * What’s New in ’22: More DOJ-Driven False Claims Act Investigations by: Pamela L. Johnston and Lisa M. Noller * SEC Says Remedy Stops Penalty: HeadSpin Avoids Fine in SEC Fraud... by: Corey I. Rogoff * New York Law Requires Employee Notice Of Electronic Monitoring by: David B. Ritter and Douglas M. Oldham * The Four Day Working Week: Revolutionising Working Life, One Day at A... by: Labor and Employment Practice Group Squire Patton Boggs * Does the Attorney-Client Privilege Protect TIAs Created Pursuant to... by: David A. Zetoony and Jena M. Valdetero * Broad Contract Exclusion Dooms Investment Firm’s $8.5 Million D&O... by: Geoffrey B. Fehling * 11 Ways Lawyers Can Broaden Their Client Base by: Stefanie M. Marrone * California's Weed Is Nevada's Flower by: Keith Paul Bishop * Litigation Minute: International Arbitration Clauses in Insurance... by: Christopher J. Valente and Jacquelyn S. Celender * The Administrative State Under Attack: Potentially Far Reaching... by: Amy B. Gordon and David A Munkittrick * FCA Stepping up Competition Law Enforcement by: Francesco Liberatore and Chris Webber FEBRUARY 06, 2022 * Top Five Labor Law Developments for January 2022 by: Jonathan J. Spitz and Richard F. Vitarelli * Prior Daubert Orders and Discovery Lessons Out of N.D. Cal. by: Peter F. Snell and Robert C. Sweeney * China Joins the Hague System for Designs by: Aaron Wininger * Illinois Supreme Court Deals a Serious Blow to Employers’ Ability to... by: Kristin L. Bryan and Brianna Soltys * New York State Department of Health Provides Self-Attesting... by: Evandro C Gigante and Laura M. Fant * NY State Secure Choice Savings Program Implementation Phase Begins by: Michelle Capezza FEBRUARY 05, 2022 * Global Private Equity- Spotlight on the Industry: Private Equity and... by: Merrick White and Elisabeth Moseley * EPA Resumes Publishing TSCA Section 8(e) Notices to ChemView by: Lynn L. Bergeson and Carla N. Hutton * Global Private Equity- Spotlight on the Industry: the Rise of... by: Mark Fine and Nicholas Jupp * Retail Industry 2021 Year in Review: The EEOC & Artificial... by: Kevin J. White and Daniel J. Butler * Global Private Equity- Spotlight on the Industry: Private Equity and... by: Aymen Mahmoud and Ryan Clarke FEBRUARY 04, 2022 * Recent Tax Developments Concerning Staking Rewards by: Andrew M. Granek and Andrea S. Kramer * Illinois Supreme Court Finds Worker’s Compensation Law Does Not... by: Mark A. Olthoff * False Claims Act: 2021 Year in Review by: Government Enforcement and Investigations Practice Group * Key Takeaways | Outlook for Competitive Power in 2022 by: Neil L. Levy and David G. Tewksbury * Beltway Buzz, February 4, 2022 by: James J. Plunkett * 2022 Mental Health Parity Report to Congress Highlights Increased... by: Helaine I. Fingold and Kevin J. Malone * Immigration Weekly Round-Up: President Biden Reauthorizes Immediate... by: William C. Menard * US Department of Labor to Hire 100 New Investigators in the Wage and... by: Felicia S. O'Connor * USCIS Releases H-1B Lottery Information: Registration Process Begins... by: Matthew P. Gunn * Global Private Equity- Spotlight on the Industry: Understanding... by: David Kiefer * Community Association Building Blocks: Community Drainage and... by: Eric J. Remington and Amy P. Wang * Retail Industry 2021 Year in Review: When Retailers Collaborate: What... by: Gregory L. Porter * Opioid Update: Court Denies Pharmacies’ Motion for Certification of... by: Kathryn (Katie) M. Brown * McDermottPlus Check-Up: February 4, 2022 by: Debra Curtis and Madeline Hodge * Cadwalader Cabinet: FSOC Can Protect Us (!) (?) (.) by: Steven Lofchie and Cadwalader, Wickersham & Taft LLP NextPrev ARTICLE BY Alejandro Luna Fandiño Gustavo A. Alcocer Armando Arenas OLIVARES RELATED PRACTICES & JURISDICTIONS * Administrative & Regulatory * Biotech, Food, Drug * Global * Health Law & Managed Care * Mexico * Printer-friendly * Email this Article * Download PDF * REPRINTS & PERMISSIONS Advertisement NEW GUIDELINES FOR GOOD MANUFACTURING PRACTICES CONCERNING MEDICAL DEVICES IN MEXICO Tuesday, January 18, 2022 After more than 10 years, the official standard of good manufacturing practices concerning medical devices has been updated. On December 20, 2021, the new version of the Official Mexican Standard NOM-241-SSA1-2021, Good medical device manufacturing practices, was published in the Official Gazette. In general terms, this new version of the standard clarifies the previous one since it focuses on giving a greater order to the specifications that must be considered in each of the stages of the life cycle of a medical device, i.e., in each step of the manufacturing chain until its distribution and marketing. In particular, the chapter on the “Quality Management System” is strengthened. Among the modifications, it is important to highlight that the scope of the definition of a medical device is extended because of technological advances, now including “…any instrument, device, utensil, machine, software, implantable product or material, diagnostic agent, material, substance or similar product to be used, alone or in combination, directly or indirectly in human beings with any of the following purposes of use indicated in the document itself”. The inclusion of the definitions of “software” as a medical device is of high relevance and solves the old loop in the regulation of software in connection with medical devices. Likewise, reference is made to the use of digital media, including digital records and the use of electronic signatures. Simultaneously, following the changes and inclusions throughout the new standard, these are reflected in the inclusion of various terms to be compatible with the new figures. We are surprised that despite the current needs of the industry and patients, and the accelerated pace of technological advancement within this field, it has been decided that the standard will come into force after 18 months of the publication in the Official Gazette last December. This standard will leave NOM-241-SSA1-2012 without effect, until it enters into force in June 2023. © 2005-2022 OLIVARES Y COMPAÑIA S.C.National Law Review, Volume XII, Number 18 * * Printer-friendly * Email this Article * Download PDF * REPRINTS & PERMISSIONS Advertisement Advertisement RELATED LEGAL HEADLINES Mexico: The Supreme Court of Justice Authorized the Industrial Use of Cannabis. By Alejandro Luna Fandiño Progress Report: US-Mexico Food Safety Agreement By Food and Drug Law at Keller and Heckman Mexico’s Supreme Court Finds General Health Law Articles Prohibiting Recreational Use of Marijuana Unconstitutional By Erick Hernández Gallego The Supreme Court of Justice Authorized the Recreational Use of Cannabis By Alejandro Luna Fandiño Advertisement TRENDING LEGAL ANALYSIS Cadwalader Cabinet February 7, 2021: Risky Business By Cadwalader, Wickersham & Taft LLP First Circuit Creates Split Regarding Federal Court Jurisdiction Over FLSA... By Ogletree, Deakins, Nash, Smoak & Stewart, P.C. Prop 65 Settlement on Lead in Infant Formula By Keller and Heckman LLP Treasury Targets Nonfungible Tokens By Hunton Andrews Kurth Advertisement Advertisement Advertisement -------------------------------------------------------------------------------- About this Author Alejandro Luna Fandiño Partner Alejandro Luna has been alternately dubbed “an extraordinary litigator, active at every level,” “responsive and insightful,” and “a knowledgeable IP practitioner offering creative and cost-effective advice” by his peers, according to IAM Patent 1000, while World Trademark Review’s WTR 1000 called him “a reliable ally for any party in a dispute”. Since joining OLIVARES in 1996 and being made partner in 2005, he has been instrumental to the firm’s IP Litigation, Regulatory, and Administrative Litigation practices. He co-chairs the Life Sciences & Pharmaceutical... alejandro.luna@olivares.mx +52 (55) 5322 3000 www.olivares.mx Gustavo A. Alcocer Partner Gustavo Alcocer manages the Corporate and Commercial Law Group at OLIVARES, advising domestic and foreign businesses and the owners of those businesses on Mexican and cross-border corporate and commercial transactions. He serves as outside general counsel in Mexico to many of his domestic and foreign clients, and also represents emerging and middle-market companies, including closely-held businesses from Mexico, the United States, Canada and Latin America. Mr. Alcocer’s significant experience on domestic and cross-border transactions allows for extensive connections with... gustavo.alcocer@olivares.mx +52 (55) 5322 3000 www.olivares.mx Armando Arenas Partner Armando Arenas joined OLIVARES in 2000 and became a partner in January 2017. He has experience working on a range of IP matters, including consulting and litigation on trademark, patent, unfair competition, trade dress protection, and misleading advertising cases before the Mexican Institute of Industrial Property (IMPI), Federal Court of Tax and Administrative Affairs (FCTA), Federal Circuit Courts (FCC) and the Supreme Court of Justice (SCJ) Regulatory Affairs and Public Acquisitions. Mr. Arenas is especially adept in patent litigation and protection under Mexico’s patent linkage system... armando.arenas@olivares.mx +52 (55) 5322 3000 Ext. 3906 www.olivares.mx Advertisement Advertisement Advertisement * Antitrust Law * Bankruptcy & Restructuring * Biotech, Food, & Drug * Business of Law * Election & Legislative * Construction & Real Estate * Environmental & Energy * Family, Estates & Trusts * Financial, Securities & Banking * Global * Health Care Law * Immigration * Intellectual Property Law * Insurance * Labor & Employment * Litigation * Cybersecurity Media & FCC * Public Services, Infrastructure, Transportation * Tax * White Collar Crime & Consumer Rights * Coronavirus News * Law Student Writing Competition * Sign Up For NLR Bulletins * Terms of Use * Privacy Policy * FAQs LEGAL DISCLAIMER You are responsible for reading, understanding and agreeing to the National Law Review's (NLR’s) and the National Law Forum LLC's Terms of Use and Privacy Policy before using the National Law Review website. The National Law Review is a free to use, no-log in database of legal and business articles. The content and links on www.NatLawReview.com are intended for general information purposes only. Any legal analysis, legislative updates or other content and links should not be construed as legal or professional advice or a substitute for such advice. No attorney-client or confidential relationship is formed by the transmission of information between you and the National Law Review website or any of the law firms, attorneys or other professionals or organizations who include content on the National Law Review website. If you require legal or professional advice, kindly contact an attorney or other suitable professional advisor. Some states have laws and ethical rules regarding solicitation and advertisement practices by attorneys and/or other professionals. The National Law Review is not a law firm nor is www.NatLawReview.com intended to be a referral service for attorneys and/or other professionals. The NLR does not wish, nor does it intend, to solicit the business of anyone or to refer anyone to an attorney or other professional. NLR does not answer legal questions nor will we refer you to an attorney or other professional if you request such information from us. Under certain state laws the following statements may be required on this website and we have included them in order to be in full compliance with these rules. The choice of a lawyer or other professional is an important decision and should not be based solely upon advertisements. Attorney Advertising Notice: Prior results do not guarantee a similar outcome. Statement in compliance with Texas Rules of Professional Conduct. Unless otherwise noted, attorneys are not certified by the Texas Board of Legal Specialization, nor can NLR attest to the accuracy of any notation of Legal Specialization or other Professional Credentials. The National Law Review - National Law Forum LLC 3 Grant Square #141 Hinsdale, IL 60521 Telephone (708) 357-3317 or toll free (877) 357-3317. If you would ike to contact us via email please click here. Copyright ©2022 National Law Forum, LLC THE NATIONAL LAW REVIEW ASKS FOR YOUR CONSENT TO USE YOUR PERSONAL DATA TO: * perm_identity Personalised ads and content, ad and content measurement, audience insights and product development * devices Store and/or access information on a device expand_moreremove Learn more * How can I change my choice? * What if I don't consent? * How does legitimate interest work? * Do I have to consent to everything? Your personal data will be processed and information from your device (cookies, unique identifiers, and other device data) may be stored by, accessed by and shared with third party vendors, or used specifically by this site or app. Some vendors may process your personal data on the basis of legitimate interest, which you can object to by managing your options below. Look for a link at the bottom of this page or in our privacy policy where you can withdraw consent. Consent Manage options arrow_back Data preferences MANAGE YOUR DATA You can choose how your personal data is used. Vendors want your permission to do the following: TCF vendors help_outline STORE AND/OR ACCESS INFORMATION ON A DEVICE Cookies, device identifiers, or other information can be stored or accessed on your device for the purposes presented to you. View details Consent SELECT BASIC ADS Ads can be shown to you based on the content you’re viewing, the app you’re using, your approximate location, or your device type. View details ConsentLegitimate interesthelp_outline CREATE A PERSONALISED ADS PROFILE A profile can be built about you and your interests to show you personalised ads that are relevant to you. View details Consent SELECT PERSONALISED ADS Personalised ads can be shown to you based on a profile about you. View details Consent CREATE A PERSONALISED CONTENT PROFILE A profile can be built about you and your interests to show you personalised content that is relevant to you. View details ConsentLegitimate interesthelp_outline SELECT PERSONALISED CONTENT Personalised content can be shown to you based on a profile about you. View details ConsentLegitimate interesthelp_outline MEASURE AD PERFORMANCE The performance and effectiveness of ads that you see or interact with can be measured. View details ConsentLegitimate interesthelp_outline MEASURE CONTENT PERFORMANCE The performance and effectiveness of content that you see or interact with can be measured. View details Consent APPLY MARKET RESEARCH TO GENERATE AUDIENCE INSIGHTS Market research can be used to learn more about the audiences who visit sites/apps and view ads. View details ConsentLegitimate interesthelp_outline DEVELOP AND IMPROVE PRODUCTS Your data can be used to improve existing systems and software, and to develop new products View details ConsentLegitimate interesthelp_outline ENSURE SECURITY, PREVENT FRAUD, AND DEBUG help_outline Your data can be used to monitor for and prevent fraudulent activity, and ensure systems and processes work properly and securely. View details TECHNICALLY DELIVER ADS OR CONTENT help_outline Your device can receive and send information that allows you to see and interact with ads and content. View details MATCH AND COMBINE OFFLINE DATA SOURCES help_outline Data from offline data sources can be combined with your online activity in support of one or more purposes View details LINK DIFFERENT DEVICES help_outline Different devices can be determined as belonging to you or your household in support of one or more of purposes. View details RECEIVE AND USE AUTOMATICALLY-SENT DEVICE CHARACTERISTICS FOR IDENTIFICATION help_outline Your device might be distinguished from other devices based on information it automatically sends, such as IP address or browser type. View details Vendor preferences Accept all Confirm choices arrow_back Vendor preferences CONFIRM OUR VENDORS Vendors can use your data to provide services. Declining a vendor can stop them from using the data you shared. TCF vendors help_outline SOVRN HOLDINGS INC Cookie duration: 365 (days). View details | Privacy policylaunch ConsentLegitimate interesthelp_outline GOOGLE ADVERTISING PRODUCTS Cookie duration: 396 (days). Uses other forms of storage. View details | Privacy policylaunch ConsentLegitimate interesthelp_outline Accept all Confirm choices Close ShareThis Copy and Paste ×